About this trial
This clinical research study is being conducted to evaluate gut and digestive health before and after the use of a dietary supplement system over an eight-week period.
Gut and digestive health play an important role in overall health, including digestion, nutrient absorption, immune function, and metabolic balance. Changes in gut microbiota, inflammation, and intestinal barrier function may contribute to digestive symptoms such as bloating, discomfort, altered bowel habits, and reduced well-being.
In this study, adult men and women with self-reported gastrointestinal symptoms will consume a dietary supplement system daily for eight weeks. The study will measure changes in gut and digestive health using objective stool-based laboratory biomarkers and validated symptom questionnaires.
Stool samples will be collected at baseline and at the end of the study to evaluate markers related to microbial diversity, inflammation, immune activity, digestive function, and intestinal barrier integrity. Participants will also complete questionnaires throughout the study to assess gastrointestinal symptoms and subjective digestive health and well-being.
The study will also monitor the safety and tolerability of the dietary supplement system during the study period.
Eligibility criteria
Qualifiers
1. Male or female adults aged 18 to 80 years (considering 50% men and 50% women, even breakdowns in age groups 18-30, 31-60, 61-80 years, and 12-15% African American required) at the time of screening.
Disqualifiers
1. Known allergy or hypersensitivity to any ingredient(s) of the study product or other herbal products.
Malabsorption disorders
Chronic gastrointestinal diseases
Severe depression
Trial design
Treatments tested in this trial
- PhytoPower 1 and PhytoPower 2
Treatment groups
Sponsors and collaborators
SF Research Institute, Inc.
Lead sponsor
Life Vantage
Collaborator